Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Innovative Medicine Revolutionizes NAD Supplements for Brain Health with First-of-Kind Nutraceutical Supplement Nadovim Backed by Years of Clinical Testing
  • USA - English


News provided by

Innovative Medicine, LLC

Sep 05, 2018, 08:10 ET

Share this article

Share toX

Share this article

Share toX

Nadovim (pronounced nad-oh-veem) is the only NAD supplement on the market that is backed by extensive research and years of clinical testing.
Nadovim (pronounced nad-oh-veem) is the only NAD supplement on the market that is backed by extensive research and years of clinical testing.

“We created Nadovim in response to the brain function decline crisis which is unlike anything we’ve ever seen,” said Thomas K. Szulc, MD.

Post this

NEW YORK (PRWEB) September 05, 2018 -- After two years in development, Innovative Medicine, LLC, announced today the availability of its revolutionary nutraceutical supplement, Nadovim. The potent cognitive enhancer and nootropic formula uses clinically-tested ratios of top-quality botanicals, minerals and nutrients which work together to provide the brain with cellular energy to function optimally. Nadovim (pronounced nad-oh-veem) is the only NAD supplement on the market that is backed by extensive research and years of clinical testing. It was designed and developed by a top pharmaceutical and nutraceutical team lead by the distinguished integrative physician, Thomas K. Szulc, MD, Medical Director at the world-renowned New York Center for Innovative Medicine.

Under Dr. Szulc’s direction, Nadovim is the first doctor-formulated, non-prescription nutraceutical supplement created to utilize NAD+ (nicotinamide adenine dinucleotide). It is one of the most important coenzymes for mitochondrial energy and has been described as acting like an “on switch” for the brain. As people age, certain genes can be triggered which accelerate degenerative processes, resulting in symptoms such as chronic fatigue, loss of mental clarity, depression, stress, anxiety and other ailments. One critical factor in this process is the coenzyme NAD+. It enables energy from the food people eat to be transferred to vital cell functions, especially in the brain. When NAD+ levels begin to decline, so does brain function.

“We created Nadovim in response to the brain function decline crisis which is unlike anything we’ve ever seen,” said Thomas K. Szulc, MD. “The two-year development of Nadovim was radically different compared to the evolution of other nutraceutical supplements. We started with leading physicians’ experiences, an extensive research and development process unlike any other, and the clinical results of patients with serious brain disorders. Nadovim’s specific combination of NAD+ with other coenzymes, herbs, minerals, amino acids and vitamins, maximizes bioavailability and may naturally increase the efficiency of energy production in the brain and central nervous system,” concluded Dr. Szulc.

Nadovim’s top benefits include the following:

• Supports overall brain health
• Improves cognitive function (kinase activity, neuronal synthesis, restoration of synaptic activity and nerve impulse transmission)
• Increases focus, concentration, and clarity of mind
• Stimulates production of dopamine, serotonin, and noradrenaline, thereby improving mood
• Reduces stress and cortisol / acts as an anti-stress agent against acute and chronic stress
• Improves memory acquisition and retention as well as problem-solving abilities
• Enhances mitochondrial function and reduces oxidative stress in the brain
• Boosts attention, cognition and impulse control
• Acts as a neuroprotectant

Nadovim is made from eight active ingredients: NAD+, Bacopa, Cat’s Claw, CoQ10, Magnesium, Thiamin, Glycine and Aspartic Acid. Each bottle contains 60 capsules and it is available for purchase on https://nadovim.com/ for $89 per bottle.

Ria Romano, Publicist, Innovative Medicine, LLC, https://nadovim.com/, +1 786-290-6413, [email protected]

Modal title

Each bottle contains 60 capsules and it is available for purchase on https://nadovim.com/ for $89 per bottle.
Each bottle contains 60 capsules and it is available for purchase on https://nadovim.com/ for $89 per bottle.
Nadovim is made from eight active ingredients: NAD+, Bacopa, Cat’s Claw, CoQ10, Magnesium, Thiamin, Glycine and Aspartic Acid.
Nadovim is made from eight active ingredients: NAD+, Bacopa, Cat’s Claw, CoQ10, Magnesium, Thiamin, Glycine and Aspartic Acid.
The potent cognitive enhancer and nootropic formula uses clinically-tested ratios of top-quality botanicals, minerals and nutrients.
The potent cognitive enhancer and nootropic formula uses clinically-tested ratios of top-quality botanicals, minerals and nutrients.
Nadovim improves cognitive function (kinase activity, neuronal synthesis, restoration of synaptic activity and nerve impulse transmission).
Nadovim improves cognitive function (kinase activity, neuronal synthesis, restoration of synaptic activity and nerve impulse transmission).
The two-year development of Nadovim was radically different compared to the evolution of other nutraceutical supplements.
The two-year development of Nadovim was radically different compared to the evolution of other nutraceutical supplements.
Nadovim was designed and developed by a top pharmaceutical and nutraceutical team lead by the distinguished integrative physician, Thomas K. Szulc, MD.
Nadovim was designed and developed by a top pharmaceutical and nutraceutical team lead by the distinguished integrative physician, Thomas K. Szulc, MD.
Each bottle contains 60 capsules and it is available for purchase on https://nadovim.com/ for $89 per bottle. Nadovim is made from eight active ingredients: NAD+, Bacopa, Cat’s Claw, CoQ10, Magnesium, Thiamin, Glycine and Aspartic Acid. The potent cognitive enhancer and nootropic formula uses clinically-tested ratios of top-quality botanicals, minerals and nutrients. Nadovim improves cognitive function (kinase activity, neuronal synthesis, restoration of synaptic activity and nerve impulse transmission). The two-year development of Nadovim was radically different compared to the evolution of other nutraceutical supplements. Nadovim was designed and developed by a top pharmaceutical and nutraceutical team lead by the distinguished integrative physician, Thomas K. Szulc, MD.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.